The limits of estimating COVID-19 intervention effects using Bayesian models

Patrick Bryant; Arne Elofsson

doi:10.1101/2020.08.14.20175240

Abstract

To limit the rapid spread of COVID-19, most governments have introduced different non-pharmaceutical interventions, which might have severe costs for society. Therefore, it is crucial to evaluate the most cost-effective interventions, using, for instance, Bayesian modelling. Such modelling efforts have deemed lockdown to account for 81% of the reduction in R₀, contributing to government policies. Here, we show that these conclusions are unsupported and that policies therefore should not be based on these studies.

https://www.eurosurveillance.org/for-authors

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

inancial support: Swedish Research Council for Natural Science, grant No. VR-2016-06301 and Swedish E-science Research Center. Computational resources: Swedish National Infrastructure for Computing, grant No. SNIC-2019/3-319.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB necessary for epidemiological studies

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data and code is available from https://github.com/patrickbryant1/COVID19.github.io/tree/master/ICL_critique

https://github.com/patrickbryant1/COVID19.github.io/tree/master/ICL_critique

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.